Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes

British Journal of Pharmacology

Volumn 132, Issue 1, 2001, Pages 159-164

  Luo, Jian Dong ^a   Xie, Fang ^a   Zhang, Wei Wen ^a   Ma, Xiao Dong ^b   Guan, Jin Xia ^a   Chen, Xiu ^c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Antioxidants; Cardiomyocyte hypertrophy; Noradrenaline; Reactive oxygen species; Signal transduction; Simvastatin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATALASE; LEUCINE; MEVALONIC ACID; NORADRENALIN; PRAZOSIN; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; RNA; SIMVASTATIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLUORESCENCE; HEART MUSCLE CELL; HYPERTROPHY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035141474     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703792     Document Type: Article

References (22)

1. Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase
2. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay
3. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine
4. Hypertrophy of isolated adult feline heart cells following α-adrenergic-induced beating
5. Flow cytometric analysis of double-stranded RNA content distributions
6. Animal safety and toxicology of simvastatin and related hydroxymethyglutary-coenzyme A reductase inhibitors
7. Regulation of the mevalonate pathway
8. Direct detection of endogenous hydroxyl radical production in cultured adult cardiomyocytes during anoxia and reoxygenation
9. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study
10. Effects of simvastatin on left ventricular hypertrophy and function in rats with aortic stenosis
11. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis
12. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy
13. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced By tumor necrosis factor-α and angiotensin II
14. Pharmacological control of the mevalonate pathway: Effect on arterial smooth muscle cell proliferation
15. Stimulation of hypertrophy of cultured neonatal rat heart cells through an α-adrenergic receptor and induction of beating through an α- and β-adrenergic receptor interaction
16. Norepinephrine-stimulated hypertrophy of cultured rat myocardial cell is an alpha, adrenergic response
17. Protective effect of fluvastatin sodium(XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A(HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro
18. Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes
19. +-ATPase to hypertrophy and its marker genes in cardiac myocytes
20. Fluvastatin, an inhibitor of a 3-hydroxy-3-methylglutaryl coenzyme A reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes
21. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both α- and β-adrenoceptors
22. Oxidation pathways for the intracellular probe 2′,7′dichlorofluorescin